A federal jury has ruled against Apple, awarding Taction Technology $5.7 billion for patent infringement related to haptic technology in iPhones and Apple Watches. Apple plans to appeal the decision, which could have significant implications for its product lineup and financial standing.
Apple Hit with $5.7 Billion Patent Verdict Over Haptic Technology
R
RDU Global Correspondent
Big Tech & Chips Desk
New York, United States Sept 26, 2026•4 min read
A federal jury has ruled against Apple, awarding Taction Technology $5.7 billion for patent infringement related to haptic technology in iPhones and Apple Watches. Apple plans to appeal the decision, which could have significant implications for its product lineup and financial standing.
Editorial & Verification Notice
Reported by RDU Global Correspondent. Formatted and verified using real-time institutional and journalistic wire feeds. Independent reporting adhering to the RDU Global Editorial Code of Conduct.
Related Coverage
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTHegseth’s Low-Testosterone Screening Plan Could Flag Up to a Quarter of the Army, Raising Medical and Readiness Concerns
A proposed low-testosterone screening initiative associated with Defense Secretary Pete Hegseth is drawing scrutiny from medical experts and military observers after estimates suggested it could identify as many as 25 percent of Army personnel. Clinicians say blanket screening is not supported by evidence and could produce false positives, unnecessary treatment, and avoidable disruption across the force.
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTGoogle’s Android Laptop Push Shows the Platform Still Has a Long Way to Go
Google’s latest attempt to bring Android to laptops underscores both the ambition and the limits of the company’s cross-device strategy. While the idea of a familiar mobile operating system on larger screens is appealing, the early reality suggests Android laptops still feel more like Android than a true desktop alternative.
Big Tech, Cloud & Semiconductors
18 Oct 2026, 05:00 PM ISTRFK Jr. Reportedly Urges FDA to Tolerate Unproven Peptides, Raising Safety and Oversight Concerns
Robert F. Kennedy Jr. has reportedly proposed that the Food and Drug Administration take a lighter-touch approach toward unproven peptide products, according to a new report. The move comes as FDA scientists say none of the popular peptide drugs have been proven safe or effective, intensifying debate over consumer protection, medical evidence, and regulatory authority.